Prevalence of diabetic retinopathy in Tehran province: a population-based study

BackgroundTo determine the prevalence and characteristics of diabetic retinopathy (DR) among Iranian patients with diabetes.MethodsDesign: population-based cross-sectional study.Participants: patients with diabetes aged 25 to 64 years in Tehran province, Iran. This survey was conducted from April to October 2007. The study sample was derived from the first national survey of risk factors for non-communicable disease. Diabetes mellitus was defined as a fasting plasma glucose of ≥ 7.0 mmol/l (126 mg/dl) or more, use of diabetic medications, or a physician's diagnosis of diabetes. All patients known to have diabetes underwent an eye examination by bio-microscope and indirect ophthalmoscope to check for any signs of DR through dilated pupils by + 78 lens. Participants were also interviewed and examined to determine their demographic characteristics, medical conditions and the regularity of their eye visits.ResultsAmong 7989 screened patients, 759 (9.5%) had diabetes. Of them, 639 patients (84.2%) underwent eye examination. Five patients (0.7%) with media opacity were excluded. Of 634 examined patients with diabetes, 240 had some degree of diabetic retinopathy, and the overall standardized prevalence of any retinopathy was 37.0% (95% CI: 33.2-40.8), including 27.3% (95% CI: 23.7-30.8) (n = 175) with non-proliferative and 9.6% (95% CI: 7.3-11.9) (n = 65) with proliferative diabetic retinopathy. Clinically significant macular edema and vision-threatening retinopathy were detected in 5.8% (95% CI: 4.0-7.7) (n = 38) and 14.0% (95% CI: 11.3-16.7) (n = 95) of patients, respectively. Only 143 patients (22.6%) with diabetes had a history of regular eye examination.ConclusionThis study demonstrated a high prevalence and poor control of DR in Tehran province. This suggests the need for adequate prevention and treatment in patients with diabetes.

[1]  T. Wong,et al.  The epidemiology of age related eye diseases in Asia , 2006, British Journal of Ophthalmology.

[2]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[3]  R. Klein,et al.  A cohort study of the relationship of diabetic retinopathy to blood pressure. , 1995, Archives of ophthalmology.

[4]  P. Gulbrandsen,et al.  Care of vision and ocular health in diabetic members of a national diabetes organization: A cross-sectional study , 2008, BMC health services research.

[5]  O. Khatib Guidelines for the Prevention Management and Care of Diabetes Mellitus , 2006 .

[6]  M. Amini,et al.  Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. , 2009, Diabetes research and clinical practice.

[7]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[8]  R. Klein,et al.  Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.

[9]  R. Klein,et al.  Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. , 2007, Ophthalmology.

[10]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[11]  P. Nirmalan,et al.  Diabetic retinopathy among self reported diabetics in southern India: a population based assessment , 2002, The British journal of ophthalmology.

[12]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[13]  M. Janghorbani,et al.  Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders , 2000, Ophthalmic epidemiology.

[14]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[15]  M. Janghorbani,et al.  Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders , 2001, Ophthalmic epidemiology.

[16]  B. Margetts United Kingdom prospective diabetes study , 1995, BMJ.

[17]  Ronald Klein,et al.  The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. , 2006, Transactions of the American Ophthalmological Society.

[18]  Stephen J. Aldington,et al.  United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. , 1998, Archives of ophthalmology.

[19]  L. Dandona,et al.  Population based assessment of diabetic retinopathy in an urban population in southern India , 1999, The British journal of ophthalmology.

[20]  I. Qayum,et al.  Dna methyltransferase 1 (DNMT1) gene activity in human lymphomas correlates with aberrant p53 gene expression. , 2006, Journal of Ayub Medical College, Abbottabad : JAMC.

[21]  M. Janghorbani,et al.  Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran , 2003, Ophthalmic epidemiology.

[22]  T. Wong,et al.  Population-based studies in ophthalmology. , 2008, American journal of ophthalmology.

[23]  K. Viswanath,et al.  Diabetic retinopathy: clinical findings and management. , 2003, Community eye health.

[24]  Tin Aung,et al.  Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. , 2008, Ophthalmology.

[25]  M. Saad,et al.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics , 1998, The British journal of ophthalmology.

[26]  K. Mohammad,et al.  PREVALENCE OF RETINAL DISEASES AND THEIR PATTERN IN TEHRAN: The Tehran Eye Study , 2008, Retina.

[27]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[28]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[29]  Fatma Al-Maskari,et al.  Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey , 2007, BMC ophthalmology.

[30]  A. Ghasemi,et al.  High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study , 2008, BMC public health.

[31]  M. C. Leske,et al.  The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.

[32]  Z. Bloomgarden,et al.  Screening for and managing diabetic retinopathy: current approaches. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[33]  Giel Nijpels,et al.  Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. , 2003, Archives of ophthalmology.

[34]  L. Bouter,et al.  Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. , 2002, Diabetes care.

[35]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[36]  H. Parving,et al.  Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. , 2006, Kidney international.

[37]  V. Mohan,et al.  Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. , 2005, Investigative ophthalmology & visual science.

[38]  M. Khan,et al.  Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. , 2006, Journal of Ayub Medical College, Abbottabad : JAMC.

[39]  E. Stefánsson,et al.  Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease. , 2006, Acta ophthalmologica Scandinavica.

[40]  T. Wong,et al.  Management of diabetic retinopathy: a systematic review. , 2007, JAMA.

[41]  C. Chen,et al.  Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. , 1992, American journal of ophthalmology.

[42]  K. Mohammad,et al.  The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study , 2004, British Journal of Ophthalmology.

[43]  L. Aiello,et al.  Systemic considerations in the management of diabetic retinopathy. , 2001, American journal of ophthalmology.

[44]  A. Esteghamati,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran , 2008, Diabetes Care.